<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
	<title>ThaiPR.NET</title>
	<atom:link href="https://www.thaipr.net/location/lund-sweden/feed" rel="self" type="application/rss+xml" />
	<link>https://www.thaipr.net/location/lund-sweden</link>
	<description>Press Release Distribution Center of Thailand</description>
	<lastBuildDate>Mon, 27 Apr 2026 14:40:01 +0700</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title><![CDATA[CRT 2023 selects Syntach Cardiac Support System for Best Innovation Competition]]></title>
		<link>https://www.thaipr.net/en/health_en/3306347</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 23 Feb 2023 17:00:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3306347</guid>

					<description><![CDATA[<p>Syntach AB (&#8220;Syntach&#8221;) is pleased to announce that the Company&#8217;s Syntach Cardiac Support system (Syntach CS) has been selected for an oral presentation in the Best Innovation Competition to be held during the CRT 2023 annual meeting taking place at the Omni Shoreham Hotel in Washington DC, February 25 &#8211; 28, 2023. The Syntach technology [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3306347">CRT 2023 selects Syntach Cardiac Support System for Best Innovation Competition</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Syntach AB announces partnership with Meditrial CRO to drive clinical development of groundbreaking Cardiac Support System]]></title>
		<link>https://www.thaipr.net/en/health_en/3301053</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Mon, 13 Feb 2023 08:00:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3301053</guid>

					<description><![CDATA[<p>Syntach AB (&#8220;Syntach&#8221;) is pleased to announce that it has entered into a partnership agreement with Meditrial Europe Ltd (&#8220;Meditrial&#8221;) to support the clinical and regulatory strategies of Syntach&#8217;s innovative minimally invasive cardiac support system. Over 64 million people suffer from heart failure, one of the most common causes of death globally. Syntach Cardiac Support [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3301053">Syntach AB announces partnership with Meditrial CRO to drive clinical development of groundbreaking Cardiac Support System</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Syntach AB announces €17.5M in Blended Funding, Names Patrick NJ Schnegelsberg as New CEO, and Appoints Cansel Isikli as VP of RA/Q]]></title>
		<link>https://www.thaipr.net/en/health_en/3296889</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Wed, 01 Feb 2023 08:10:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3296889</guid>

					<description><![CDATA[<p>Swedish medtech startup Syntach AB has been awarded up to €15 million in equity financing by European Innovation Council (EIC) for the development of the Syntach Cardiac Support System, a breakthrough device for patients with heart failure. This approval follows the award of a €2.5 million grant from the EIC announced by Syntach AB in [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3296889">Syntach AB announces €17.5M in Blended Funding, Names Patrick NJ Schnegelsberg as New CEO, and Appoints Cansel Isikli as VP of RA/Q</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Syntach AB awarded an EU grant of € 2.5 million]]></title>
		<link>https://www.thaipr.net/en/health_en/3136886</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Wed, 22 Dec 2021 08:00:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3136886</guid>

					<description><![CDATA[<p>Syntach AB in Lund, Sweden has been awarded € 2.5 million as a grant and part of blended finance of up to € 17,5 million from the European Innovation Council (EIC) to support the development of its unique minimally invasive cardiac support system. Over 60 million people suffer from heart failure, and it is one [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3136886">Syntach AB awarded an EU grant of € 2.5 million</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Stem cell therapy company Amniotics raises SEK 60 million before deduction of transaction costs, in First North IPO to advance lead candidate PulmoStem™ into clinic]]></title>
		<link>https://www.thaipr.net/en/health_en/3074527</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Mon, 12 Jul 2021 13:00:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3074527</guid>

					<description><![CDATA[<p>Novel source of stem cells in full-term amniotic fluid provides basis for broad pipeline Amniotics AB (publ) (&#8220;Amniotics&#8221; or the &#8220;Company&#8221;), a stem cell therapy company has raised SEK60 million through its recent listing on Nasdaq First North Growth Market. The offering was fully subscribed and attracted widespread interest from Swedish investment companies and family [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3074527">Stem cell therapy company Amniotics raises SEK 60 million before deduction of transaction costs, in First North IPO to advance lead candidate PulmoStem™ into clinic</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
	</channel>
</rss>
